• Utila integrates Injective, aligning with a leading DeFi ecosystem for seamless asset transfers and strategic growth.
• Utila expands to asset tokenization on Injective, enhancing institutional clients’ ability to manage Real-World Assets efficiently.

In a tweet, Injective announced that the top institutional MPC wallet, Utila, has natively integrated Injective into its system, having successfully processed over $3 billion in asset transfers to date.

This integration with Injective is more than just a technical improvement; it is also a strategic partnership with one of the most advanced decentralized finance (DeFi) ecosystems.

Utila’s Strategic Integration with Injective Expands DeFi Capabilities and Embraces Asset Tokenization 

Injective, well-known for its cutting-edge technology and decentralized derivatives trading, offers a reliable platform for smooth financial operations. By partnering with Injective, Utila positions itself to benefit from the booming DeFi market, providing its institutional clients with new options and capabilities.

Furthermore, Utila’s integration with Injective goes beyond simple asset transfers. The wallet provider is also expanding its offerings to include asset tokenization, which is quickly becoming a critical component of the digital asset ecosystem.

Asset tokenization provides a simple approach for institutions to onboard and manage Real-World Assets (RWA) on Injective, allowing them to diversify their portfolios and explore new revenue streams.

This functionality is especially useful for institutions looking to provide new RWA products while keeping the process efficient and secure.

Utila’s asset tokenization capabilities enable a seamless transfer from traditional to digital assets, allowing institutions to tokenize real estate, commodities, and even intellectual property.

These tokenized assets can then be traded, managed, and transferred via the Injective platform, giving institutional investors a significant level of flexibility and security.

Previously, CNF noted that Injective has collaborated with Elliptic to improve network security and regulatory compliance.

Elliptic’s set of products enables developers and enterprises to easily trace cash flows inside the Injective network while adhering to global regulatory standards. In addition, we highlighted Injective’s ability to handle more than $200 million over its native DEX.

Furthermore, earlier this month, Injective announced the release of Injective Altaris on the mainnet, which is the most powerful chain update yet. Altaris improves scalability and provides advanced smart contract features, establishing Injective as a formidable participant in the DeFi field.

Meanwhile, its native token, INJ, is trading at $17.27, up 7.87% over the last 24 hours, and daily trading volume has increased by 39.64% to $126.17 million.